Cargando…
Spontaneous regression of tumours. Possible cross reactivity of autoantibodies against carbonic anhydrase I
Spontaneous tumour regression in patients after high dose therapy and autologous stem cell transplantation or patients with standard therapy is accompanied with the presence of high titers autoantibodies against carbonic anhydrase I (CA I). The concomitant presence of aplastic anaemia‐like syndrome...
Autor principal: | Lakota, Ján |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660616/ https://www.ncbi.nlm.nih.gov/pubmed/37776059 http://dx.doi.org/10.1111/jcmm.17970 |
Ejemplares similares
-
Autoimmune phenomena and spontaneous tumour regression. The role of carbonic anhydrase I
por: Minichová, Lenka, et al.
Publicado: (2021) -
Sera of patients with spontaneous tumour regression and elevated anti‐CA I autoantibodies change the gene expression of ECM proteins
por: Lakota, Jan, et al.
Publicado: (2016) -
Silencing of carbonic anhydrase I enhances the malignant potential of exosomes secreted by prostatic tumour cells
por: Bánová Vulić, Radivojka, et al.
Publicado: (2019) -
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
por: Menteşe, Ahmet, et al.
Publicado: (2017) -
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
por: Mentese, Ahmet, et al.
Publicado: (2017)